John Mellors, MD

Professor of Medicine
University of Pittsburgh

Disclosure: Abound Bio (Individual(s) Involved: Self): Shareholder; Accelevir Diagnostics (Individual(s) Involved: Self): Consultant; Co-Crystal Pharmaceuticals (Individual(s) Involved: Self): Shareholder; Gilead (Individual(s) Involved: Self): Consultant, Grant/Research Support; Merck (Individual(s) Involved: Self): Consultant

Presentation(s):

• 108 - Selective Decay of Intact HIV-1 Proviral DNA on Antiretroviral Therapy

  Oral Abstract

• 124 - Six-year Longitudinal Analysis of an Inpatient Infectious Diseases Telemedicine Service at a Community Hospital

  Oral Abstract